Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of Mycoses

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Bayer
ClinicalTrials.gov Identifier:
NCT00722189
First received: July 14, 2008
Last updated: February 25, 2014
Last verified: February 2014

July 14, 2008
February 25, 2014
July 2008
January 2009   (final data collection date for primary outcome measure)
Efficacy of Travogen / Travocort in the treatment of skin mycoses / Travogen Cream and Travocort Cream will be prescribed by a physician [ Time Frame: Baseline to end of study ] [ Designated as safety issue: No ]
Efficacy of Travogen / Travocort in the treatment of skin mycoses [ Time Frame: Baseline to end of study ] [ Designated as safety issue: No ]
Complete list of historical versions of study NCT00722189 on ClinicalTrials.gov Archive Site
Patient satisfaction [ Time Frame: Baseline to end of study ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Observational Study of Efficacy and Safety of Travogen Cream and Travocort Cream in the Treatment of Mycoses
Observational Study of the Efficacy, Safety and Tolerance of Travogen Cream (Isoconazole) and Travocort Cream (Isoconazole, Diflurcortolone) in the Treatment of Patients With Local Skin Mycosis of Various Etiology and Localization

An assessment of the efficacy and safety of Travogen cream and Travocort cream in the treatment of local skin mycoses

Not Provided
Observational
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Patients with diagnosed skin mycoses

Skin Mycoses
Not Provided
A
All patients treated
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
900
February 2009
January 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Diagnosis of skin mycosis

Exclusion Criteria:

  • Allergies to study medication
Both
Not Provided
No
Contact information is only displayed when the study is recruiting subjects
Russian Federation
 
NCT00722189
2008/01850
No
Bayer
Bayer
Not Provided
Study Director: Bayer Study Director Bayer
Bayer
February 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP